Free Trial

International Biotechnology (IBT) Competitors

International Biotechnology logo
GBX 636 -2.00 (-0.31%)
As of 03/28/2025 12:41 PM Eastern

IBT vs. TRY, CGT, RICA, JEO, NBPE, APEO, SAIN, TMPL, SLPE, and IEM

Should you be buying International Biotechnology stock or one of its competitors? The main competitors of International Biotechnology include TR Property Investment Trust (TRY), Capital Gearing (CGT), Ruffer Investment (RICA), European Opportunities Trust (JEO), NB Private Equity Partners (NBPE), abrdn Private Equity Opportunities (APEO), Scottish American Investment (SAIN), Temple Bar (TMPL), Standard Life Private Equity Trust (SLPE), and Impax Environmental Markets (IEM). These companies are all part of the "asset management" industry.

International Biotechnology vs.

TR Property Investment Trust (LON:TRY) and International Biotechnology (LON:IBT) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, TR Property Investment Trust's average media sentiment score of 0.00 equaled International Biotechnology'saverage media sentiment score.

Company Overall Sentiment
TR Property Investment Trust Neutral
International Biotechnology Neutral

TR Property Investment Trust pays an annual dividend of GBX 15 per share and has a dividend yield of 5.1%. International Biotechnology pays an annual dividend of GBX 29 per share and has a dividend yield of 4.6%. TR Property Investment Trust pays out 16.8% of its earnings in the form of a dividend. International Biotechnology pays out 27.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. TR Property Investment Trust is clearly the better dividend stock, given its higher yield and lower payout ratio.

TR Property Investment Trust has higher revenue and earnings than International Biotechnology. TR Property Investment Trust is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TR Property Investment Trust£311.14M3.03£284.71M£89.423.32
International Biotechnology£41.82M5.46£37.91M£104.806.07

TR Property Investment Trust has a net margin of 91.50% compared to International Biotechnology's net margin of 90.66%. TR Property Investment Trust's return on equity of 24.54% beat International Biotechnology's return on equity.

Company Net Margins Return on Equity Return on Assets
TR Property Investment Trust91.50% 24.54% -24.58%
International Biotechnology 90.66%13.67%3.57%

TR Property Investment Trust has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, International Biotechnology has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500.

International Biotechnology received 16 more outperform votes than TR Property Investment Trust when rated by MarketBeat users. Likewise, 77.71% of users gave International Biotechnology an outperform vote while only 68.18% of users gave TR Property Investment Trust an outperform vote.

CompanyUnderperformOutperform
TR Property Investment TrustOutperform Votes
120
68.18%
Underperform Votes
56
31.82%
International BiotechnologyOutperform Votes
136
77.71%
Underperform Votes
39
22.29%

45.6% of TR Property Investment Trust shares are held by institutional investors. Comparatively, 45.2% of International Biotechnology shares are held by institutional investors. 5.0% of TR Property Investment Trust shares are held by insiders. Comparatively, 4.2% of International Biotechnology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

TR Property Investment Trust beats International Biotechnology on 9 of the 15 factors compared between the two stocks.

Remove Ads
Get International Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for IBT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IBT vs. The Competition

MetricInternational BiotechnologyAsset Management IndustryFinancial SectorLON Exchange
Market Cap£228.46M£1.14B£4.19B£2.62B
Dividend Yield4.20%4.42%4.19%4.82%
P/E Ratio6.0726.4615.97141.21
Price / Sales5.462,259.461,695.16284,295.48
Price / Cash155.7460.8149.0728.19
Price / Book0.831.113.354.60
Net Income£37.91M£260.27M£1.28B£5.84B
7 Day Performance-2.45%-0.44%-0.19%1.43%
1 Month Performance-7.29%-2.30%6.13%7.42%
1 Year Performance-3.05%3.41%9.47%31.20%

International Biotechnology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IBT
International Biotechnology
N/AGBX 636
-0.3%
N/A-3.0%£228.46M£41.82M6.07N/A
TRY
TR Property Investment Trust
N/AGBX 293.58
+0.7%
N/A-8.6%£933.20M£311.14M3.2826
CGT
Capital Gearing
N/AGBX 4,813.49
+0.2%
N/A+2.2%£895.19M£17.92M19.57N/A
RICA
Ruffer Investment
N/AGBX 275.65
-0.1%
N/A+3.9%£886.98M£16.91M100.27N/A
JEO
European Opportunities Trust
N/AN/AN/AN/A£886.70M£-62,326,000.00-12.93N/A
NBPE
NB Private Equity Partners
N/AGBX 1,526
-0.1%
N/A-5.7%£885.09M£12.90M-40.02N/A
APEO
abrdn Private Equity Opportunities
N/AN/AN/AN/A£880.29M£80.21M1,435.00N/A
SAIN
Scottish American Investment
N/AGBX 503.32
+0.1%
N/A-0.9%£880.09M£75.38M10.09N/ANews Coverage
TMPL
Temple Bar
N/AGBX 301.03
+0.3%
N/A+24.1%£861.19M£157.64M5.59N/AEarnings Report
News Coverage
SLPE
Standard Life Private Equity Trust
N/AGBX 560
flat
N/A+3.9%£860.98M£251.60M3.61N/A
IEM
Impax Environmental Markets
N/AGBX 363.05
+0.3%
N/A-11.8%£842.82M£1.35M-90.30N/ANegative News
Remove Ads

Related Companies and Tools


This page (LON:IBT) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners